It was an extremely busy week in the biotech sector, with several companies ... The acquisition adds to GSK’s growing portfolio in gastrointestinal (GI) cancers, including ongoing trials with ...

CEO J.D. Finley promised that the biotech is “in the midst of encouraging discussions that we believe will lead to pipeline expansion opportunities in high value indications in the GI space.” ...

Vaxcyte, Inc. (NASDAQ:PCVX), standing sixth among the best performing biotech stocks in 2024 ... VAX-PG for periodontal disease, and VAX-GI for Shigella. In Q3 2024, Vaxcyte, Inc. (NASDAQ:PCVX ...

After a rough start to the year, biotech stocks have been on an upswing, standing out in a difficult market for high-growth stocks. These notoriously volatile names have outperformed the broad ...

With the market struggling amid rising recession fears, now may be the ideal time to consider biotech stocks. First, the sector itself is a financially lucrative one. Last year, the ecosystem ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Discover outperforming stocks and invest smarter with ...

and there are still more than 100 biotech stocks worth less than the cash they have in the bank. Yet there are also very clear signs that the worst might be over for the sector. For investors with ...

However, investors were disappointed and the stock fell following the announcement ... to GSK’s growing portfolio in gastrointestinal (GI) cancers, including ongoing trials with dostarlimab ...